Top U.S. proton pump inhibitors based on revenue 2013

This statistic displays the top ten proton pump inhibitors based on total U.S. revenue in 2013. In that year, Aciphex was among the leading proton pump inhibitors generating a total of 693 million U.S. dollars in revenue in the United States. Proton pump inhibitors are drugs that aid in the long-term reduction of gastric acid production. It is often used to treat conditions such as peptic ulcer disease and Barrett's esophagus.

Top proton pump inhibitors based on U.S. revenue in 2013

Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2014

Region

United States

Survey time period

2013

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.